These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15119285)
1. What are STIs and what are the goals of STIs? Proj Inf Perspect; 2004 Jan; (37):16-8. PubMed ID: 15119285 [TBL] [Abstract][Full Text] [Related]
2. New developments in STIs and SIT. Proj Inf Perspect; 2000 Oct; (31):5. PubMed ID: 12171020 [TBL] [Abstract][Full Text] [Related]
3. Structured treatment interruptions--new findings. Benson CA Top HIV Med; 2006; 14(3):107-11. PubMed ID: 16946455 [TBL] [Abstract][Full Text] [Related]
4. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment. Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420 [TBL] [Abstract][Full Text] [Related]
5. Structured treatment interruptions in chronic HIV management: where next? Pai NP; Klein MB Expert Rev Anti Infect Ther; 2006 Dec; 4(6):909-12. PubMed ID: 17181404 [No Abstract] [Full Text] [Related]
6. The latest on structured treatment interruptions. Proj Inf Perspect; 2000 Aug; (30):7-8. PubMed ID: 12171016 [TBL] [Abstract][Full Text] [Related]
8. HIV treatment series. Treatment interruptions. Reviewing what we've learned so far. Staszow K Posit Aware; 2006; 17(3):37-40. PubMed ID: 16791962 [No Abstract] [Full Text] [Related]
9. CD4 cell count-guided treatment interruption: be smart and wait for more evidence. Arduino R Clin Infect Dis; 2005 Mar; 40(5):735-7. PubMed ID: 15714421 [No Abstract] [Full Text] [Related]
10. Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption. León A; Martinez E; Milinkovic A; Mora B; Mallolas J; Blanco JL; Larrousse M; Laguno M; Gallart T; Plana M; Gatell JM; Garcia F J Antimicrob Chemother; 2009 Jan; 63(1):184-8. PubMed ID: 19001447 [TBL] [Abstract][Full Text] [Related]
11. [New trend in HIV therapy. Later treatment onset and structured pauses]. Jäger H MMW Fortschr Med; 2001 Apr; 143 Suppl 1():32-5. PubMed ID: 11373773 [TBL] [Abstract][Full Text] [Related]
13. Researchers note changing patterns of HIV morbidity. Study suggests benefit to starting ART early. AIDS Alert; 2007 Oct; 22(10):116-7. PubMed ID: 18416008 [No Abstract] [Full Text] [Related]
14. CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART. Maggiolo F; Airoldi M; Callegaro A; Martinelli C; Dolara A; Bini T; Gregis G; Quinzan G; Ripamonti D; Ravasio V; Suter F AIDS; 2009 Apr; 23(7):799-807. PubMed ID: 19114869 [TBL] [Abstract][Full Text] [Related]
15. Safety and factors predicting the duration of first and second treatment interruptions guided by CD4+ cell counts in patients with chronic HIV infection. Boschi A; Tinelli C; Ortolani P; Arlotti M J Antimicrob Chemother; 2006 Mar; 57(3):520-6. PubMed ID: 16387747 [TBL] [Abstract][Full Text] [Related]